A detailed history of Kuhn & CO Investment Counsel transactions in Pfizer Inc stock. As of the latest transaction made, Kuhn & CO Investment Counsel holds 14,560 shares of PFE stock, worth $389,043. This represents 0.37% of its overall portfolio holdings.

Number of Shares
14,560
Previous 14,470 0.62%
Holding current value
$389,043
Previous $402 Million 1.46%
% of portfolio
0.37%
Previous 0.38%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$25.26 - $29.6 $2,273 - $2,664
90 Added 0.62%
14,560 $407 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $374,628 - $430,193
14,470 New
14,470 $402 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kuhn & CO Investment Counsel Portfolio

Follow Kuhn & CO Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kuhn & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Kuhn & CO Investment Counsel with notifications on news.